Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/10/2024, as per the latest filing. These shares, valued at an aggregate market value of $2,063.36, were originally acquired on 10/10/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. The planned sale follows a significant transaction history over the past three months, where a total of 249,984 shares were sold for gross proceeds of approximately $228,106.92. The notice of the upcoming sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.

Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 06/10/2024, as per the latest filing. These shares, valued at an aggregate market value of $2,063.36, were originally acquired on 10/10/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. The planned sale follows a significant transaction history over the past three months, where a total of 249,984 shares were sold for gross proceeds of approximately $228,106.92. The notice of the upcoming sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.